Management of the neonate whose mother received suppressive acyclovir therapy during late pregnancy.
Prober
C G
CG
Stanford University School of Medicine, Palo Alto, CA, USA.
D000212:Acyclovir / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects* / Q000196:embryology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D012008:Recurrence; D016896:Treatment Outcome
D000998:Antiviral Agents; D000212:Acyclovir